AZD1222 US Phase III trial met primary efficacy endpoint in preventing COVID-19 at interim analysis Read more
Everest Medicines Announces Acceptance of New Drug Application by China NMPA for Xerava for the Treatment of Complicated Intra-abdominal Infections Read more
Oramed Forms a Joint Venture, Oravax Medical Inc., for the Development of Novel Oral COVID-19 Vaccines Read more
Invite from Justin Mason-Home, Chair at SMi’s 5th Annual Highly Potent Active Pharmaceutical Ingredients 2021 Read more
Pyxis Oncology Announces Worldwide Licensing Agreement with Pfizer to Develop and Commercialize Multiple Antibody-Drug Conjugates Read more
Boston Pharmaceuticals Enters into Unique Multi-Year Out-License and Option Agreement with GSK for the Advancement of Multiple Pre-Phase 2 Programs Read more